This article was generated by an automated content engine and was reviewed by a human editor prior to publication. For additional information, read Senseonics’s 8K filing here.
Senseonics Company Profile
Senseonics Holdings, Inc, a medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company's products include Eversense, Eversense XL, and Eversense E3 that are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management.
See Also
- Five stocks we like better than Senseonics
- What is MarketRank™? How to Use it
- GM’s Lithium Americas Deal Positions It for EV Dominance
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Amazon: Why Analysts Think It’s A Solid Buy Ahead Of Earnings
- Most Volatile Stocks, What Investors Need to Know
- NextEra’s Diverse Business Is Set to Win As Energy Demand Rises
